Methods for predicting the response to anti-cancer treatment with an agonist of TLR7 or an agonist of TLR8
View Patent ↗The present invention relates to methods for predicting the response to treatment with an agonist of TLR7, or an agonist of TLR8 or an anti-cancer agent for treating cancer, in particular non-small cell lung cancer comprising the step of detecting the expression of TLR7 or TLR8 in cancer cells of said patient.
1. A method for treating a cancer patient who does not express TLR7 in cancer cells comprising
determining whether said cancer patient expresses TLR7 in cancer cells; and
administering a therapeutically effective amount of an agonist of TLR7 if said cancer patient does not express TLR7 in cancer cells.
2. The method of claim 1 wherein said agonist is used in combination with an anti-cancer agent.
3. The method of claim 1 , wherein said cancer is selected from the group consisting of lung cancer, breast cancer, colorectal cancer, renal carcinoma, prostate cancer, melanoma, and lymphoma.
4. The method of claim 1 , wherein said cancer is a solid cancer.